RAEJEANNE NUTTER: Open Payments
NPI 1538775705 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 75 payments from 16 companies in 2025. Trend: 2023 $243 · 2024 $900 · 2025 $1,333
Food & beverage: $1,333
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $265 |
| Lilly USA, LLC | 11 | $233 |
| Novo Nordisk Inc | 10 | $152 |
| ABBVIE INC. | 13 | $148 |
| GlaxoSmithKline, LLC. | 6 | $103 |
| Aimmune Therapeutics, Inc. | 5 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| PFIZER INC. | 3 | $52 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $49 |
Products named: MOUNJARO, FARXIGA, Ozempic, TRELEGY ELLIPTA, UBRELVY, ZENPEP, AIRSUPRA, BREZTRI.
Industry payments across OH — which companies pay providers there.
